Distribution of circulating natural killer cells and T lymphocytes in head and neck squamous cell carcinoma

Auris Nasus Larynx

Volumn 40, Issue 2, 2013, Pages 216-221

  Böttcher, Arne ^a   Ostwald, Jürgen ^b   Guder, Ellen ^b   Pau, Hans Wilhelm ^b   Kramp, Burkhard ^b   Dommerich, Steffen ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Changes after treatment; HNSCC; Lymphocyte subsets; NK cells; Peripheral distribution; T cells

Indexed keywords

ADULT; ARTICLE; CELL ISOLATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; T CELL DEPLETION; T LYMPHOCYTE; VENOUS BLOOD;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS;

EID: 84875374454     PISSN: 03858146     EISSN: 18791476     Source Type: Journal    
DOI: 10.1016/j.anl.2012.07.004     Document Type: Article

References (34)

1. Burnet F.M. The concept of immunological surveillance. Prog Exp Tumor Res 1970, 13:1-27.
2. Reichert T., DeBruyère M., Deneys V., Tötterman T., Lydyard P., Yuksel F., et al. Lymphocyte subset reference ranges in adult Caucasians. Clin Immunol Immunopathol 1991, 60:190-208.
3. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat Immunol 2008, 9:503-510.
4. Kärre K. Natural killer cell recognition of missing self. Nat Immunol 2008, 9:477-480.
5. Srivastava S., Lundqvist A., Childs R.W. Natural killer cell immunotherapy for cancer: a new hope. Cytotherapy 2008, 10:775-783.
6. Agada F.O., Alhamarneh O., Stafford N.D., Greenman J. Immunotherapy in head and neck cancer: current practice and future possibilities. J Laryngol Otol 2009, 123:19-28.
7. Berzins S.P., Smyth M.J., Baxter A.G. Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol 2011, 11:131-142.
8. Jerud E.S., Bricard G., Porcelli S.A. CD1d-restricted natural killer T cells: roles in tumor immunosurveillance and tolerance. Transfus Med Hemother 2006, 33:18-36.
9. Whiteside T.L. Immunobiology of head and neck cancer. Cancer Metastasis Rev 2005, 24:95-105.
10. Kross K.W., Heimdal J.H., Aarstad H.J. Mononuclear phagocytes in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2010, 267:335-344.
11. Bisset L.R., Lung T.L., Kaelin M., Ludwig E., Dubs R.W. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland. Eur J Haematol 2004, 72:203-212.
12. Backteman K., Ernerudh J. Biological and methodological variation of lymphocyte subsets in blood of human adults. J Immunol Methods 2007, 322:20-27.
13. Jentsch-Ullrich K., Koenigsmann M., Mohren M., Franke A. Lymphocyte subsets' reference ranges in an age- and gender-balanced population of 100 healthy adults - a monocentric German study. Clin Immunol 2005, 116:192-197.
14. Caruso A., Licenziati S., Corulli M., Canaris A.D., De Francesco M.A., Fiorentini S., et al. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry 1997, 27:71-76.
15. Molling J.W., Langius J.A., Langendijk J.A., Leemans C.R., Bontkes H.J., van der Vliet H.J., et al. Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma. J Clin Oncol 2007, 25:862-868.
16. Wulff S., Pries R., Börngen K., Trenkle T., Wollenberg B. Decreased levels of circulating regulatory NK cells in patients with head and neck cancer throughout all tumor stages. Anticancer Res 2009, 29:3053-3057.
17. UICC (International Union Against Cancer). In: Sobin LH, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumors. 7th ed., Oxford: Blackwell; 2010 (German Translation: UICC 2010, TNM-Klassifikation maligner Tumoren. Herausgegeben und übersetzt von Wittekind C, Meyer HJ. 7. Auflage. Weinheim: Wiley VCH; 2010).
18. Colucci F., Caligiuri M.A., Di Santo J.P. What does it take to make a natural killer?. Nat Rev Immunol 2003, 3:413-425.
19. Ferlazzo G., Münz C. NK cell compartments and their activation by dendritic cells. J Immunol 2004, 172:1333-1339.
20. Ostwald J., Dommerich S., Schulz U., Kramp B. Long-term changes in peripheral blood leukocyte and lymphocyte populations in ENT-carcinoma patients. A flow cytometric study in 346 ENT-carcinoma patients and 31 healthy controls. HNO 2004, 52:685-692.
21. Mendenhall W.M., Hinerman R.W., Amdur R.J., Malyapa R.S., Lansford C.D., Werning J.W., et al. Postoperative radiotherapy for squamous cell carcinoma of the head and neck. Clin Med Res 2006, 4:200-208.
22. 2) in hypertonic saline. Cancer Treat Rep 1986, 70:820-821.
23. Eisenthal A., Eytan K., Brazowski E., Katz B.Z., Shirazi I., Skornick Y. Effects of 5-fluorouracil on human mitogen-activated peripheral blood lymphocytes from healthy individuals. Anticancer Res 2008, 28:3785-3791.
24. Kitayama J., Yasuda K., Kawai K., Sunami E., Nagawa H. Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer. BMC Cancer 2011, 11:64.
25. Crompton N.E., Miralbell R., Rutz H.P., Ersoy F., Sanal O., Wellmann D., et al. Altered apoptotic profiles in irradiated patients with increased toxicity. Int J Radiat Oncol Biol Phys 1999, 45:707-714.
26. Eric A., Juranic Z., Tisma N., Plesinac V., Borojevic N., Jovanovic D., et al. Radiotherapy-induced changes of peripheral blood lymphocyte subpopulations in cervical cancer patients: relationship to clinical response. J BUON 2009, 14:79-83.
27. Santin A.D., Hermonat P.L., Ravaggi A., Bellone S., Roman J., Pecorelli S., et al. Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int J Radiat Oncol Biol Phys 2000, 48:997-1006.
28. Konjevic G., Spuzic I. Evaluation of different effects of sera of breast cancer patients on the activity of natural killer cells. J Clin Lab Immunol 1992, 38:83-93.
29. Bauernhofer T., Kuss I., Henderson B., Baum A.S., Whiteside T.L. Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer. Eur J Immunol 2003, 33:119-124.
30. Mozaffari F., Lindemalm C., Choudhury A., Granstam-Björneklett H., Helander I., Lekander M., et al. NK-cell and T-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo- and radiotherapy. Br J Cancer 2007, 97:105-111.
31. Uppaluri R., Dunn G.P., Lewis J.S. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers. Cancer Immun 2008, 8:16.
32. Allen C.T., Judd N.P., Bui J.D., Uppaluri R. The clinical implications of antitumor immunity in head and neck cancer. Laryngoscope 2012, 122:144-157.
33. Husmann G, Kaatsch P, Katalinic A, Bertz J, Haberland J, Kraywinkel K, Wolf U. Mundhöhle und Pharynx. In: Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V., editors. Krebs in Deutschland 2005/2006. Häufigkeiten und Trends, 7th ed. Berlin; 2010. p. 24-27.
34. Michiels S., Le Maitre A., Buyse M., Burzykowski T., Maillard E., Bogaerts J., et al. Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data. Lancet Oncol 2009, 10:341-350.